InnoCan Pharma Corporation
INNO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.67% | 53.84% | 12.37% | -21.47% | -37.28% |
| Total Receivables | 52.00% | -3.99% | 186.34% | 185.60% | 179.41% |
| Inventory | 103.57% | 87.79% | 103.12% | 54.47% | 73.68% |
| Prepaid Expenses | -53.94% | -50.60% | 41.99% | -24.94% | -27.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.97% | 2.94% | 33.01% | 32.69% | 37.14% |
| Total Current Assets | 40.78% | 49.20% | 42.43% | -1.08% | -18.13% |
|
|
|||||
| Total Current Assets | 40.78% | 49.20% | 42.43% | -1.08% | -18.13% |
| Net Property, Plant & Equipment | -11.94% | -14.08% | -9.22% | 38.78% | 44.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 39.75% | 47.68% | 41.29% | -0.52% | -17.44% |
|
|
|||||
| Total Accounts Payable | -60.36% | 119.77% | 65.05% | 17.89% | 139.57% |
| Total Accrued Expenses | -- | -- | -- | 45.60% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 57.14% | -- |
| Total Finance Division Other Current Liabilities | 24.93% | 227.87% | 417.34% | 540.13% | 126.49% |
| Total Other Current Liabilities | 24.93% | 227.87% | 417.34% | 540.13% | 126.49% |
| Total Current Liabilities | 12.85% | 205.96% | 318.78% | 247.88% | 128.25% |
|
|
|||||
| Total Current Liabilities | 12.85% | 205.96% | 318.78% | 247.88% | 128.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -93.75% | -84.62% | -73.08% | -45.00% | -36.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.13% | 197.55% | 309.16% | 240.08% | 124.36% |
|
|
|||||
| Common Stock & APIC | 9.46% | 11.83% | 10.94% | 6.93% | 5.37% |
| Retained Earnings | -8.09% | -14.39% | -17.53% | -16.56% | -18.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 19.73% | -3.61% | -24.79% | -35.83% | -42.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.73% | -3.61% | -24.79% | -35.83% | -42.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 812.76% | 30,475.00% | 569.29% | 267.46% | 195.15% |
| Total Equity | 54.28% | 20.75% | -11.84% | -29.54% | -38.04% |
|
|
|||||
